 - Patients who are currently treated with drugs known to be strong inhibitors or inducers of isoenzyme cytochrome P450, family 3, subfamily A CYP3A, and the treatment cannot be discontinued or switched to a different medication prior to starting study drug please note that co-treatment with weak and moderate inhibitors and inducers of CYP3A is allowed 